Gylden Pharma Limited
- Company number
- 09955881
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 18 Jan 2016
- Nature of business
- Research and experimental development on biotechnology
Registered office
Previous names
- Emergex Vaccines Holding Limited (until 16 Oct 2024)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MARCHINI, Fabricio Klerynton | Director | 27 Aug 2026 | |
| FLANAGAN, Tony | Director | 9 Jul 2026 | |
| DE GODOI MATTOS FERREIRA, Ricardo, Dr | Director | 27 Sep 2023 | 27 Aug 2026 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Professor Thomas William Rademacher | Significant Influence Or Control | 6 Apr 2016 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Mar 2025 | -£3,337,403 | £294,382 | 39 |
| 31 Mar 2024 | £1,799,977 | £517,012 | 35 |
| 31 Mar 2023 | - | - | - |
| 31 Mar 2022 | - | - | - |
| 31 Mar 2021 | - | - | - |
| 31 Mar 2020 | - | - | - |
| 31 Mar 2019 | - | - | - |
| 31 Mar 2018 | - | - | - |
| 31 Mar 2017 | - | - | - |